The point of a clinical trial is not only to assess whether a medication is effective, but also whether it is safe
The main benefits of GLP-1 therapy include: Enhanced insulin secretion in response to meals Reduced glucagon release, preventing high blood sugar levels Slowed gastric emptying, leading to prolonged satiety Decreased appetite, which may help with weight loss Currently available GLP-1 receptor agonists include drugs like liraglutide (Victoza), semaglutide (Ozempic, Wegovy), exenatide (Byetta), and dulaglutide (Trulicity)
754-P: effect of retatrutide on kidney parameters in people with type 2 diabetes and/or obesity a post-hoc analysis of two phase 2 trials
#Diabetes #DiabetesCare #GlycemicControl #ChronicDiseaseManagement #Endocrinology #PatientCare #MedicalEducation #ClinicalPractice #Healthcare #DoctorsOfLinkedIn #PreventiveMedicine To view or add a comment, sign in This study supports the safe use of metformin in transplant recipients living with diabetes, demonstrating an association with improved survival and cardiovascular outcomes and graft preservation
Stress and anxiety can lead to racing thoughts at bedtime, making it difficult to fall asleep
Tirzepatide (Zepbound, Mounjaro) produces 22.5% average weight loss and is the closest approved analog to retatrutides efficacy level
